EXICURE, INC. (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Address
2430 N. HALSTED ST.
CHICAGO, IL 60614
Founded
2011
Number of Employees
6
Website
http://www.exicuretx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)